Evolution of rituximab use over time in moderate-to-severe pemphigus: A two-centre retrospective study
Ann Dermatol Venereol. 2024 Mar 28;151(2):103265. doi: 10.1016/j.annder.2024.103265. Online ahead of print.NO ABSTRACTPMID:38552270 | DOI:10.1016/j.annder.2024.103265 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - March 29, 2024 Category: Dermatology Authors: M Hazard C Bedane O Ducharme P Bernard A-L Pham-Ledard Source Type: research

Pemphigoid of the pulmonary system
Ann Dermatol Venereol. 2024 Mar 27;151(2):103253. doi: 10.1016/j.annder.2024.103253. Online ahead of print.NO ABSTRACTPMID:38547598 | DOI:10.1016/j.annder.2024.103253 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - March 28, 2024 Category: Dermatology Authors: A R Ahmed M Kalesinskas Source Type: research

Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients
CONCLUSION: Our study confirms the value of RTX maintenance therapy in pemphigus in real life.PMID:38537431 | DOI:10.1016/j.annder.2024.103264 (Source: Annales de Dermatologie et de Venereologie)
Source: Annales de Dermatologie et de Venereologie - March 27, 2024 Category: Dermatology Authors: A Louchez T El Aarbaoui A Weill O Gaudin L Jelti T Belmondo P Wolkenstein S Ingen-Housz-Oro Source Type: research